Agios Pharm (AGIO) Insider Trading
- $153,404,205.75
- $155,562,864.87
- Sept. 26, 2024
- Scott Biller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 8, 2016 | Insider | 27,500 | $65.00 | Sell | $1,787,500.00 | |
May 26, 2016 | Director | 2,504 | $51.69 | Sell | $129,431.76 | |
April 26, 2016 | Director | 2,504 | $53.44 | Sell | $133,813.76 | |
April 25, 2016 | Director | 627 | $55.00 | Sell | $34,485.00 | |
March 30, 2016 | Director | 2,504 | $37.19 | Sell | $93,123.76 | |
Feb. 26, 2016 | Director | 2,504 | $37.90 | Sell | $94,901.60 | |
Jan. 29, 2016 | Director | 2,504 | $42.93 | Sell | $107,496.72 | |
Dec. 29, 2015 | Director | 10,664 | $64.93 | Sell | $692,413.52 | |
Dec. 15, 2015 | COO | 20,000 | $50.09 | Sell | $1,001,800.00 | |
Nov. 17, 2015 | Director | 9,408 | $59.83 | Sell | $562,880.64 | |
Nov. 16, 2015 | COO | 20,000 | $61.51 | Sell | $1,230,200.00 | |
Nov. 2, 2015 | insider | 5,500 | $77.12 | Sell | $424,160.00 | |
Oct. 23, 2015 | Director | 9,704 | $61.16 | Sell | $593,496.64 | |
Oct. 15, 2015 | COO | 20,000 | $71.04 | Sell | $1,420,800.00 | |
Sept. 30, 2015 | insider | 5,500 | $70.44 | Sell | $387,420.00 | |
Sept. 25, 2015 | Director | 9,704 | $83.25 | Sell | $807,858.00 | |
Sept. 24, 2015 | SVP | 6,000 | $85.97 | Sell | $515,820.00 | |
Sept. 15, 2015 | COO | 20,000 | $91.11 | Sell | $1,822,200.00 | |
Aug. 18, 2015 | Director | 9,704 | $94.94 | Sell | $921,297.76 | |
Aug. 17, 2015 | COO | 20,000 | $92.24 | Sell | $1,844,800.00 | |
July 23, 2015 | SVP | 7,000 | $120.45 | Sell | $843,150.00 | |
July 20, 2015 | Insider | 5,500 | $113.87 | Sell | $626,285.00 | |
July 17, 2015 | SVP | 13,000 | $113.71 | Sell | $1,478,230.00 | |
July 16, 2015 | COO | 20,000 | $114.02 | Sell | $2,280,400.00 | |
July 16, 2015 | Director | 9,704 | $114.28 | Sell | $1,108,973.12 | |
June 25, 2015 | Director | 9,704 | $105.13 | Sell | $1,020,181.52 | |
June 15, 2015 | COO | 7,000 | $105.23 | Sell | $736,610.00 | |
June 8, 2015 | Insider | 5,500 | $121.85 | Sell | $670,175.00 | |
June 1, 2015 | CEO | 13,000 | $120.67 | Sell | $1,568,710.00 | |
June 1, 2015 | Insider | 5,000 | $120.67 | Sell | $603,350.00 | |
May 27, 2015 | SVP | 2,171 | $120.05 | Sell | $260,628.55 | |
May 27, 2015 | CEO | 8,929 | $120.05 | Sell | $1,071,926.45 | |
May 20, 2015 | Director | 9,704 | $116.64 | Sell | $1,131,874.56 | |
May 15, 2015 | COO | 7,417 | $112.89 | Sell | $837,305.13 | |
May 12, 2015 | CEO | 5,200 | $110.02 | Sell | $572,104.00 | |
May 8, 2015 | CEO | 3,900 | $101.32 | Sell | $395,148.00 | |
May 7, 2015 | Insider | 5,500 | $96.32 | Sell | $529,760.00 | |
April 24, 2015 | Director | 9,704 | $105.15 | Sell | $1,020,375.60 | |
April 15, 2015 | COO | 6,583 | $99.54 | Sell | $655,271.82 | |
April 13, 2015 | CEO | 3,900 | $100.03 | Sell | $390,117.00 | |
April 8, 2015 | Insider | 5,500 | $97.64 | Sell | $537,020.00 | |
April 1, 2015 | CEO | 3,900 | $92.54 | Sell | $360,906.00 | |
March 27, 2015 | Director | 9,704 | $93.58 | Sell | $908,100.32 | |
March 16, 2015 | SVP | 10,000 | $106.24 | Sell | $1,062,400.00 | |
March 16, 2015 | COO | 7,000 | $106.24 | Sell | $743,680.00 | |
March 16, 2015 | Insider | 5,500 | $106.81 | Sell | $587,455.00 | |
March 2, 2015 | CEO | 7,800 | $107.05 | Sell | $834,990.00 | |
Feb. 13, 2015 | CEO | 1,471 | $120.22 | Sell | $176,843.62 | |
Feb. 13, 2015 | SVP | 1,316 | $120.31 | Sell | $158,327.96 | |
Feb. 11, 2015 | SVP | 16,513 | $107.12 | Sell | $1,768,872.56 |
Insiders are both buying and selling Agios Pharm stock.
The insider traders at Agios Pharm are: Scott Biller, David P Schenkein, Lewis Clayton Jr. Cantley, John Duncan Higgons, Glenn Goddard, Christopher Bowden, Steven L Hoerter, Theodore James Jr. Washburn, Carman Alenson, Brian Goff, Jacqualyn A Fouse, James William Burns, John Maraganore, Cecilia Jones, Kaye I Foster-Cheek, Celgene European Investment Co, Robert Nelsen, Darrin Miles, Corp /De/ Celgene, Tsveta Milanova, Sarah Gheuens, and David Scadden
The most active insider trader at Agios Pharm is Scott Biller with 46 trades.
David P Schenkein has sold the most Agios Pharm stock with a total value of $52,693,359.25.
Celgene European Investment Co has bought the most Agios Pharm stock with a total value of $112,876,552.75.
The most recent insider trade for Agios Pharm was on Sept. 26, 2024.
The single biggest insider buy for Agios Pharm was from Corp /De/ Celgene with a total value of $57,027,318.00 on Jan. 23, 2018.
The single biggest insider sell for Agios Pharm was from Robert Nelsen with a total value of $11,998,527.52 on Feb. 28, 2017.